LU80470A1 - "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. - Google Patents
"noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. Download PDFInfo
- Publication number
- LU80470A1 LU80470A1 LU80470A LU80470A LU80470A1 LU 80470 A1 LU80470 A1 LU 80470A1 LU 80470 A LU80470 A LU 80470A LU 80470 A LU80470 A LU 80470A LU 80470 A1 LU80470 A1 LU 80470A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- group
- formula
- compound
- acid
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4612877 | 1977-11-05 | ||
GB4612877 | 1977-11-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU80470A1 true LU80470A1 (fr) | 1980-06-05 |
Family
ID=10439957
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU80470A LU80470A1 (fr) | 1977-11-05 | 1978-11-03 | "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. |
LU88331C LU88331I2 (fr) | 1977-11-05 | 1993-06-24 | Doxazosin (Cardura) |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU88331C LU88331I2 (fr) | 1977-11-05 | 1993-06-24 | Doxazosin (Cardura) |
Country Status (36)
Country | Link |
---|---|
JP (1) | JPS5498792A (fi) |
AR (2) | AR219562A1 (fi) |
AT (1) | AT365186B (fi) |
AU (1) | AU509329B2 (fi) |
BE (1) | BE871771A (fi) |
CA (1) | CA1088059A (fi) |
CH (1) | CH643255A5 (fi) |
CS (2) | CS207671B2 (fi) |
DD (1) | DD139850A5 (fi) |
DE (1) | DE2847623C2 (fi) |
DK (1) | DK154082C (fi) |
EG (1) | EG13594A (fi) |
ES (2) | ES474805A1 (fi) |
FI (1) | FI64366C (fi) |
FR (1) | FR2407929A1 (fi) |
GR (1) | GR81514B (fi) |
HK (1) | HK94284A (fi) |
HU (1) | HU176306B (fi) |
IE (1) | IE47888B1 (fi) |
IL (1) | IL55857A (fi) |
IN (1) | IN148828B (fi) |
IT (1) | IT1100919B (fi) |
KE (1) | KE3350A (fi) |
LU (2) | LU80470A1 (fi) |
MY (1) | MY8500286A (fi) |
NL (2) | NL174549C (fi) |
NO (1) | NO150158C (fi) |
NZ (1) | NZ188813A (fi) |
PH (1) | PH13966A (fi) |
PL (2) | PL119419B1 (fi) |
PT (1) | PT68735A (fi) |
SE (1) | SE437518B (fi) |
SU (1) | SU816403A3 (fi) |
UA (1) | UA8324A1 (fi) |
YU (2) | YU40204B (fi) |
ZA (1) | ZA786184B (fi) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986002644A1 (en) * | 1984-11-01 | 1986-05-09 | Takeda Chemical Industries, Ltd. | 1,5-benzoxathiepin derivatives and process for their preparation |
WO1985002617A1 (en) * | 1983-12-14 | 1985-06-20 | Takeda Chemical Industries. Ltd. | 1,5-benzoxathiepin derivatives and process for their preparation |
WO1985004658A1 (en) * | 1984-04-04 | 1985-10-24 | Takeda Chemical Industries, Ltd. | 1,5-benzoxathiepine derivatives and their preparation |
EP0849264A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von doxazosinmesylat (Form I) |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
ES2282997T3 (es) * | 1996-12-20 | 2007-10-16 | Heumann Pcs Gmbh | Nueva forma polimorfa de mesilato e doxazosina (forma iii). |
TW448155B (en) * | 1999-03-29 | 2001-08-01 | Dev Center Biotechnology | Method for producing amide compounds and quinazolin derivatives |
EP1403263B1 (en) * | 2002-09-27 | 2005-06-22 | Council of Scientific and Industrial Research | Process for the preparation of N-(2,3-dihydrobenzo 1,4 dioxin-2-carbonyl) piperazine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3635979A (en) * | 1969-09-29 | 1972-01-18 | Pfizer | Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines |
US3669968A (en) * | 1970-05-21 | 1972-06-13 | Pfizer | Trialkoxy quinazolines |
-
1978
- 1978-09-27 DK DK428678A patent/DK154082C/da active
- 1978-10-03 IN IN712/DEL/78A patent/IN148828B/en unknown
- 1978-10-24 PH PH21726A patent/PH13966A/en unknown
- 1978-10-24 CA CA314,027A patent/CA1088059A/en not_active Expired
- 1978-10-31 SU SU782679598A patent/SU816403A3/ru active
- 1978-10-31 UA UA2679598A patent/UA8324A1/uk unknown
- 1978-11-02 IL IL55857A patent/IL55857A/xx unknown
- 1978-11-02 CS CS787166A patent/CS207671B2/cs unknown
- 1978-11-02 HU HU78PI648A patent/HU176306B/hu unknown
- 1978-11-02 DE DE2847623A patent/DE2847623C2/de not_active Expired
- 1978-11-02 NL NLAANVRAGE7810909,A patent/NL174549C/xx not_active IP Right Cessation
- 1978-11-02 AT AT0784378A patent/AT365186B/de not_active IP Right Cessation
- 1978-11-02 PT PT68735A patent/PT68735A/pt unknown
- 1978-11-02 JP JP13569578A patent/JPS5498792A/ja active Granted
- 1978-11-02 NZ NZ188813A patent/NZ188813A/xx unknown
- 1978-11-02 AR AR274321A patent/AR219562A1/es active
- 1978-11-02 YU YU2553/78A patent/YU40204B/xx unknown
- 1978-11-02 GR GR57562A patent/GR81514B/el unknown
- 1978-11-02 ZA ZA00786184A patent/ZA786184B/xx unknown
- 1978-11-02 FI FI783347A patent/FI64366C/fi not_active IP Right Cessation
- 1978-11-02 CH CH1132178A patent/CH643255A5/de not_active IP Right Cessation
- 1978-11-02 SE SE7811382A patent/SE437518B/sv not_active IP Right Cessation
- 1978-11-03 ES ES474805A patent/ES474805A1/es not_active Expired
- 1978-11-03 IE IE2179/78A patent/IE47888B1/en active Protection Beyond IP Right Term
- 1978-11-03 IT IT29434/78A patent/IT1100919B/it active Protection Beyond IP Right Term
- 1978-11-03 PL PL1978216980A patent/PL119419B1/pl unknown
- 1978-11-03 NO NO783705A patent/NO150158C/no unknown
- 1978-11-03 PL PL1978210681A patent/PL119586B1/pl unknown
- 1978-11-03 AU AU41322/78A patent/AU509329B2/en not_active Expired
- 1978-11-03 BE BE191544A patent/BE871771A/xx not_active IP Right Cessation
- 1978-11-03 LU LU80470A patent/LU80470A1/fr unknown
- 1978-11-03 DD DD78208868A patent/DD139850A5/de unknown
- 1978-11-03 FR FR7831126A patent/FR2407929A1/fr active Granted
- 1978-11-04 EG EG641/78A patent/EG13594A/xx active
-
1979
- 1979-04-30 ES ES480121A patent/ES480121A0/es active Granted
- 1979-10-18 AR AR278545A patent/AR223015A1/es active
-
1983
- 1983-02-17 YU YU386/83A patent/YU40419B/xx unknown
- 1983-11-21 KE KE3350A patent/KE3350A/xx unknown
-
1984
- 1984-11-29 HK HK942/84A patent/HK94284A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY286/85A patent/MY8500286A/xx unknown
-
1991
- 1991-11-22 CS CS913544A patent/CS354491A3/cs unknown
-
1993
- 1993-06-11 NL NL930062C patent/NL930062I2/nl unknown
- 1993-06-24 LU LU88331C patent/LU88331I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0307303B1 (fr) | [(Pyrimidinyl-2)-aminoalkyl]-1 pipéridines, leur préparation et leur application en thérapeutique | |
FR2689888A1 (fr) | Nouveaux dérivés de pérhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent. | |
EP0354094B1 (fr) | Dérivés d'indolone, leur préparation et leur application en thérapeutique | |
FR2561244A1 (fr) | Composes heterocycliques du type tetrahydrocarbazolone, procede pour leur preparation et composition pharmaceutique les comprenant | |
CA2104883A1 (fr) | Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant | |
EP0338939B1 (fr) | Dérivé de l'histamine, sa préparation et son application en thérapeutique | |
EP0049555A1 (fr) | Nouveaux dérivés de l'acide 2-trifluorométhyl-4-hydroxy-3-quinoline carboxylique et leur procédé de préparation | |
FR2637591A1 (fr) | Derives de quinoleinone, leur preparation et leur application en therapeutique | |
EP1828125B1 (fr) | Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine | |
LU80470A1 (fr) | "noveaux derives de 4-animo-2-(piperazin-1-yl ou homopipe-razin-1-yl)-quinazoline, leur procede de production et composition pharmaceutique les contenant. | |
CA2055326A1 (fr) | Derives de la n-benzoyl proline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
CA1095047A (fr) | Procede de preparation de nouveaux derives du 1,4- benzodioxane | |
US7776852B2 (en) | Process for producing highly pure midazolam and salts thereof | |
JPH0150698B2 (fi) | ||
EP0524846A1 (fr) | Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique | |
EP0147312B1 (fr) | Nouvelles imidazo /1,2-c/ pyrimidines et leurs sels, leur procédé de préparation, leur application à titre de médicaments et les compositions les renfermant | |
DD249271A5 (de) | Verfahren zur herstellung von 9-chlor-1,5-benzothiazepin-derivaten | |
EP0635002B1 (fr) | Nouveaux derives de perhydroisoindole, et leur preparation | |
CA2557942A1 (fr) | Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique | |
EP0402232A1 (fr) | Dérivés de pyridobenzoindole, leur préparation et les compositions qui les contiennent | |
EP1492792B1 (fr) | Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide,leur preparation et leur application en therapeutique | |
AP899A (en) | Indole derivatives useful in therapy. | |
EP0302787B1 (fr) | Dérivés de (pipéridinyl-4)méthyl-2 benzofuro[2,3-c]pyridines, leur préparation et leur application en thérapeutique | |
FR2697251A1 (fr) | N-oxydes de dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl] pipéridin-1-yl]éthanol, leur procédé de préparation et leur application en thérapeutique. | |
WO2012168664A1 (fr) | 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl] propoxy}benzamide, son procede de preparation et les compositions pharmaceutiques qui le contiennent |